Recurrent Breast Cancer Completed Phase 1 / 2 Trials for Denileukin diftitox (DB00004)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00425672ONTAKĀ® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous TreatmentTreatment